Cargando…
Investigating a novel multiplex proteomics technology for detection of changes in serum protein concentrations that may correlate to tumor burden
Background: To account for cancer heterogeneity, we previously introduced the concept of “personalized” tumor markers, which are biomarkers that are informative in subsets of patients or even a single patient. Recent developments in various multiplex protein technologies create excitement for the di...
Autores principales: | Ren, Annie He, Prassas, Ioannis, Soosaipillai, Antoninus, Jarvi, Stephanie, Gallinger, Steven, Kulasingam, Vathany, Diamandis, Eleftherios P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682495/ https://www.ncbi.nlm.nih.gov/pubmed/33274048 http://dx.doi.org/10.12688/f1000research.24654.2 |
Ejemplares similares
-
Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden
por: Ren, Annie, et al.
Publicado: (2021) -
Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification
por: Ren, Annie H., et al.
Publicado: (2021) -
A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019) -
Correction to: A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019) -
Towards personalized tumor markers
por: Kulasingam, Vathany, et al.
Publicado: (2017)